{
     "PMID": "24568372",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20140527",
     "LR": "20141120",
     "IS": "1520-4804 (Electronic) 0022-2623 (Linking)",
     "VI": "57",
     "IP": "6",
     "DP": "2014 Mar 27",
     "TI": "Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.",
     "PG": "2549-67",
     "LID": "10.1021/jm401824w [doi]",
     "AB": "We have synthesized a family of rhein-huprine hybrids to hit several key targets for Alzheimer's disease. Biological screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Abeta42 and tau antiaggregating activity, and brain permeability. Ex vivo studies with the leads (+)- and (-)-7e in brain slices of C57bl6 mice have revealed that they efficiently protect against the Abeta-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a positive effect on the induction of long-term potentiation. In vivo studies in APP-PS1 transgenic mice treated ip for 4 weeks with (+)- and (-)-7e have shown a central soluble Abeta lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP). Thus, (+)- and (-)-7e emerge as very promising disease-modifying anti-Alzheimer drug candidates.",
     "FAU": [
          "Viayna, Elisabet",
          "Sola, Irene",
          "Bartolini, Manuela",
          "De Simone, Angela",
          "Tapia-Rojas, Cheril",
          "Serrano, Felipe G",
          "Sabate, Raimon",
          "Juarez-Jimenez, Jordi",
          "Perez, Belen",
          "Luque, F Javier",
          "Andrisano, Vincenza",
          "Clos, M Victoria",
          "Inestrosa, Nibaldo C",
          "Munoz-Torrero, Diego"
     ],
     "AU": [
          "Viayna E",
          "Sola I",
          "Bartolini M",
          "De Simone A",
          "Tapia-Rojas C",
          "Serrano FG",
          "Sabate R",
          "Juarez-Jimenez J",
          "Perez B",
          "Luque FJ",
          "Andrisano V",
          "Clos MV",
          "Inestrosa NC",
          "Munoz-Torrero D"
     ],
     "AD": "Laboratori de Quimica Farmaceutica (Unitat Associada al CSIC), Facultat de Farmacia, Universitat de Barcelona , Av. Joan XXIII 27-31, E-08028 Barcelona, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140310",
     "PL": "United States",
     "TA": "J Med Chem",
     "JT": "Journal of medicinal chemistry",
     "JID": "9716531",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Anthraquinones)",
          "0 (Cholinesterase Inhibitors)",
          "0 (Enzyme Inhibitors)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (1-42))",
          "0 (tau Proteins)",
          "EC 3.4.- (Amyloid Precursor Protein Secretases)",
          "EC 3.4.23.- (Aspartic Acid Endopeptidases)",
          "EC 3.4.23.46 (BACE1 protein, human)",
          "YM64C2P6UX (rhein)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*drug therapy",
          "Amyloid Precursor Protein Secretases/antagonists & inhibitors",
          "Amyloid beta-Peptides/antagonists & inhibitors",
          "Amyloid beta-Protein Precursor/antagonists & inhibitors",
          "Animals",
          "Anthraquinones/*chemical synthesis/pharmacology",
          "Aspartic Acid Endopeptidases/antagonists & inhibitors",
          "Binding Sites",
          "Blood-Brain Barrier/drug effects",
          "Cholinesterase Inhibitors/chemical synthesis/pharmacology",
          "Enzyme Inhibitors/*chemical synthesis/pharmacology",
          "Escherichia coli/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Humans",
          "In Vitro Techniques",
          "Kinetics",
          "Long-Term Potentiation/drug effects",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Models, Molecular",
          "Peptide Fragments/antagonists & inhibitors",
          "Stereoisomerism",
          "Synapses/metabolism",
          "tau Proteins/antagonists & inhibitors"
     ],
     "EDAT": "2014/02/27 06:00",
     "MHDA": "2014/05/28 06:00",
     "CRDT": [
          "2014/02/27 06:00"
     ],
     "PHST": [
          "2014/02/27 06:00 [entrez]",
          "2014/02/27 06:00 [pubmed]",
          "2014/05/28 06:00 [medline]"
     ],
     "AID": [
          "10.1021/jm401824w [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Med Chem. 2014 Mar 27;57(6):2549-67. doi: 10.1021/jm401824w. Epub 2014 Mar 10.",
     "term": "hippocampus"
}